| NovaVision is the first and leading
provider of computerised vision therapies for vision impairments
as a result of neurological damage sustained as a result
of a stroke, brain damage or brain tumors.
VRT is based on
research done at the Institute for Medical Psychology
of the Otto-von-Guericke University in Magdeburg,
Germany (IMP) und was clinical tested for
years. Our VRT constantly incorporates the latest
scientific
results from numerous research projects with renowned
scientists, neurologists, ophthalmologists and health
insurances.
VRT was awarded the international EU-Technological
Prize for the best innovation (2000) and is recognised
by the American health authority, the Food and Drug
Administration (FDA).
|
